These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9069609)
21. [Pharmacoeconomics in uro-oncology: the concept of QALYs]. Poulsen Nautrup B Urologe A; 2011 Dec; 50(12):1573-7. PubMed ID: 22159702 [TBL] [Abstract][Full Text] [Related]
22. The usefulness of ratios for allocation decisions: the case of stroke. Ament A; Evers S; Baltussen R Cerebrovasc Dis; 2000; 10(4):283-8. PubMed ID: 10878433 [TBL] [Abstract][Full Text] [Related]
23. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses. Bala MV; Zarkin GA; Mauskopf JA Value Health; 2002; 5(4):338-46. PubMed ID: 12102696 [TBL] [Abstract][Full Text] [Related]
24. An assessment of economic measures used in menorrhagia: a systematic review. Sanghera S; Frew E; Kai J; Gupta J; Elizabeth Roberts T Soc Sci Med; 2013 Dec; 98():149-53. PubMed ID: 24331893 [TBL] [Abstract][Full Text] [Related]
25. Inquiry into the relationship between equity weights and the value of the QALY. Bobinac A; van Exel NJ; Rutten FF; Brouwer WB Value Health; 2012 Dec; 15(8):1119-26. PubMed ID: 23244815 [TBL] [Abstract][Full Text] [Related]
27. Application of cost-effectiveness analysis to multiple products: a practical guide. Bala MV; Zarkin GA Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971 [TBL] [Abstract][Full Text] [Related]
28. Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year). Gafni A; Birch S; Mehrez A J Health Econ; 1993 Oct; 12(3):325-39. PubMed ID: 10129840 [TBL] [Abstract][Full Text] [Related]
29. Are quality of life, patient preferences, and costs realistic outcomes for clinical trials? Rusthoven JJ Support Care Cancer; 1997 Mar; 5(2):112-7. PubMed ID: 9069610 [TBL] [Abstract][Full Text] [Related]
30. The role of health economics in clinical decision-making: is it ethical? Williams A Respir Med; 1991 Sep; 85 Suppl B():3-5. PubMed ID: 1759019 [TBL] [Abstract][Full Text] [Related]
31. QALYs and mental health care. Chisholm D; Healey A; Knapp M Soc Psychiatry Psychiatr Epidemiol; 1997 Feb; 32(2):68-75. PubMed ID: 9050347 [TBL] [Abstract][Full Text] [Related]
32. Limits to rationality: economics, economists and priority setting. Robinson R Health Policy; 1999 Oct; 49(1-2):13-26. PubMed ID: 10827288 [TBL] [Abstract][Full Text] [Related]
33. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813 [TBL] [Abstract][Full Text] [Related]
34. QALYs for resource allocation: probably not and certainly not now. Burrows C; Brown K Aust J Public Health; 1993 Sep; 17(3):278-86. PubMed ID: 8286505 [TBL] [Abstract][Full Text] [Related]
35. Equity weights in the allocation of health care: the rank-dependent QALY model. Bleichrodt H; Diecidue E; Quiggin J J Health Econ; 2004 Jan; 23(1):157-71. PubMed ID: 15154692 [TBL] [Abstract][Full Text] [Related]
36. [Economic evaluation of targeted cancer therapy]. Ikeda S Gan To Kagaku Ryoho; 2013 Aug; 40(8):967-70. PubMed ID: 23986036 [TBL] [Abstract][Full Text] [Related]
37. The QALY--a measure of social value rather than individual utility? Nord E Health Econ; 1994; 3(2):89-93. PubMed ID: 8044215 [TBL] [Abstract][Full Text] [Related]
39. The QALY: a guide for the public health physician. Petrou S; Renton A Public Health; 1993 Sep; 107(5):327-36. PubMed ID: 8248467 [TBL] [Abstract][Full Text] [Related]